Helping the Community and the World One Patient at a Time
Current Enrolling Clinical Trials
Celgene /Bristol Myers Squibb ENLIGHTEN
A Multicenter, Longitudinal, Open-Label, Single -Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063)
Lundbeck NA, Ltd.
A Clinical study of Patients with Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy.
Novartis - Exchange
Exploring the safety and tolerability of conversion from oral or injectable disease modifying therapies to dose titrated Oral Siponimod in patients with advancing forms of relapsing multiple sclerosis
EMD - Serono
The study will evaluate the efficacy and safety of evobrutinib administered orally twice daily versus Interferon-beta-1a (Avonex®), once a week intramuscularly in participants with Relapsing Multiple Sclerosis (RMS).
Current enrolling clinical trials
Actellion
Multicenter, Randomized, Double-blind, Parallel-group, add-on, Superiority Study to compare the efficacy and safety of Ponesimod to placebo in subjects with active Relapsing Multiple Sclerosis who are treated with Dimethyl Fumarate (Tecfidera)
Genentech Inc.
Genentech WA40404
A phase IIIb multi-center, randomized double-blind, placebo controlled study to evaluate the efficacy and safety of Ocrelizumab in adults with primary progressive multiple sclerosis.
Coming Soon
Adamas Pharmaceuticals, Inc.
A 2-Arm, Multicenter, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Efficacy and Safety of ADS-5102 Amantadine Extended Release Capsules in Multiple Sclerosis Patients with Walking Impairment.
Coming Soon
Addex ADX48621-301
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ADX48621 in the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease